Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia
- 57 Downloads
Twelve febrile patients with severe neutropenia, who had undergone aggressive chemotherapy for acute myeloid leukemia, were treated empirically with a continuous infusion of ceftazidime 100 mg/kg/day after a 500 mg loading dose, in order to study the pharmacokinetics of ceftazidime after continuous infusion and to examine the clinical applicability of continuous infusion in this patient population. Three patients had a slight decrease in renal function. All patients attained a steady-state ceftazidime serum level of >20 µg/ml within 180 to 240 min, which was considered effective against most pathogens in neutropenic patients. The median volume of distribution for the patient group was 29.1 I, the elimination half-life was 2.5 h and the clearance of ceftazidime was 7.7 l/h. A subnormal kidney function influenced half-lives and clearance (but not volume of distribution), as expected. When precautions were taken to avoid known interactions between ceftazidime and other compounds to be infused simultaneously, continuous infusion of ceftazidime was applicable for treatment of neutropenic patients without major side effects.
Unable to display preview. Download preview PDF.
- 7.Mc Donald PJ, Craig WA, Kunin CM: Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. Journal of Infectious Diseases 1977, 135: 217–223.Google Scholar
- 8.Craig WA, Ebert SC: Killing and regrowth of bacteria in vitro: a review. Scandinavian Journal of Infectious Diseases 1991, Supplement 74: 63–70.Google Scholar
- 10.Leggett JE, Ebert S, Fantin B, Craig WA: Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh infection and pneumonitis models. Scandinavian Journal of Infectious Diseases 1991, Supplement 74: 179–184.Google Scholar
- 11.Thijs JP, Vanderkelen B, Klastersky J: Pharmacological study of cefazolin during intermittent and continuous infusion: a cross-over investigation in humans. Antimicrobial Agents and Chemotherapy 1976, 10: 395–398.Google Scholar
- 13.Daenen S, de Vries-Hospers H: Cure ofPseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime. Lancet 1988, i: 937.Google Scholar
- 15.Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin M, Skelton J, Thaler M, Wesley R: A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 1986, 315: 552–558.PubMedGoogle Scholar